You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Renal threshold for glucose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Kidney Diseases, Diabetes, PreDiabetes Trial in Vienna (Therapeutic carbohydrate restriction combined with an

Recruiting
  • Chronic Kidney Diseases
  • +3 more
  • Therapeutic carbohydrate restriction combined with an SGLT-2-Inhibitor
  • Vienna, Austria
    6th Medical Department with Nephrology and Dialysis, Clinik Otta
Oct 16, 2023

Chronic Kidney Disease, Diabetes, Type 2, Hypertension Trial in Genova (Dapagliflozin 10mg Tab, Placebo)

Recruiting
  • Chronic Kidney Disease
  • +2 more
  • Dapagliflozin 10mg Tab
  • Placebo
  • Genova, GE, Italy
    IRCCS Ospedale Policlinico San Martino
Aug 10, 2023

Kidney Failure, Chronic Trial in La Roche-sur-Yon, Nantes (Tacrolimus)

Recruiting
  • Kidney Failure, Chronic
  • La Roche-sur-Yon, France
  • +1 more
Oct 21, 2022

Type 1 Diabetes Trial in Montreal (other, device, drug)

Recruiting
  • Type 1 Diabetes
  • Test to induce a decline in plasma glucose
  • +3 more
  • Montreal, Quebec, Canada
    Montreal Clinical Research Institute
Oct 7, 2022

Diabetes, Diabetes, Type 1, Diabetes, Type 2 Trial in Charlottesville (Continuous Glucose Monitor)

Completed
Has Results
  • Diabetes
  • +2 more
  • Continuous Glucose Monitor
  • Charlottesville, Virginia
    Meaghan Stumpf, MD
Nov 29, 2022

Diuresis Under Eletrical Stimulation Trial in Zürich (electrical stimulation (non painful) of the lower urinary tract to

Suspended
  • Diuresis Under Eletrical Stimulation
  • electrical stimulation (non painful) of the lower urinary tract to determine the current perception threshold and record sensory evoked potentials
  • Zürich, Switzerland
    Balgrist University Hospital
Aug 23, 2022

Diabetes, Type 2 Trial in San Antonio (Dapagliflozin, Placebo)

Active, not recruiting
  • Diabetes Mellitus, Type 2
  • San Antonio, Texas
    University of Texas Health Science Center
Aug 5, 2022

Renal Transplant Failure Trial in London (Envarsus, Adoport)

Withdrawn
  • Renal Transplant Failure
  • London, United Kingdom
    Barts Health NHS Trust
Mar 21, 2022

A Study of Sleeve Gastrectomy Risks and Benefits

Enrolling by invitation
  • Renal Failure
  • 6 minutes walk distance
  • +6 more
  • Rochester, Minnesota
    Mayo Clinic Minnesota
Oct 4, 2023

Cardiorenal Syndrome Trial in New Haven (Dapagliflozin)

Not yet recruiting
  • Cardiorenal Syndrome
  • New Haven, Connecticut
    Yale New Haven Hospital
Oct 26, 2023

Diabetes Complication, Renal Impairment Trial in Uddevalla (Simultanious CGM/FGM)

Active, not recruiting
  • Diabetes Mellitus Complication
  • Renal Impairment
  • Simultanious CGM/FGM
  • Uddevalla, Sweden
    NU-Hospital Group
May 2, 2022

Patients With Diabetes on Peritoneal Dialysis

Not yet recruiting
  • Kidney Disease, Chronic
  • +2 more
    • (no location specified)
    Oct 2, 2023

    End Stage Renal Disease Trial (Carry Life UF, 2.27% glucose peritoneal dialysis dwell)

    Not yet recruiting
    • End Stage Renal Disease
    • Carry Life UF
    • 2.27% glucose peritoneal dialysis dwell
    • (no location specified)
    May 15, 2023

    Diabetes Trial in Manhasset (device, diagnostic test, drug)

    Enrolling by invitation
    • Diabetes Mellitus
    • Continuous Glucose Monitor Application
    • +3 more
    • Manhasset, New York
      North Shore University Hospital
    Jan 28, 2022

    Nephropathy, Diabetic Nephropathies, Diabetes, Type 1 Trial in Herlev (Sotagliflozin, Placebo)

    Not yet recruiting
    • Nephropathy
    • +6 more
    • Herlev, Denmark
      Steno Diabetes Center Copenhagen
    Nov 19, 2023

    Chronic Kidney Diseases, Bone Diseases, Metabolic Trial in Mansoura (Dapagliflozin 10mg Tab, Placebo)

    Active, not recruiting
    • Chronic Kidney Diseases
    • Bone Diseases, Metabolic
    • Dapagliflozin 10mg Tab
    • Placebo
    • Mansoura, Aldakahliya, Egypt
      Urology and Nephrology center, Mansoura University
    Feb 16, 2023

    Cardiac Arrhythmia in Patients With End-Stage Renal Disease

    Active, not recruiting
    • End Stage Renal Disease on Dialysis
    • +3 more
    • Loop recorder (Reveal LINQ, Medtronic)
    • Continuous Glucose Measurement (G6, Dexcom)
    • Copenhagen, Denmark
    • +3 more
    Oct 25, 2022

    Kidney Cancer, Renal Cell Carcinoma, Clear Cell Carcinoma Trial in Dallas (13C-Glucose, 13C-Acetate, 13C-Lactate)

    Recruiting
    • Kidney Cancer
    • +11 more
    • 13C-Glucose
    • +4 more
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Dec 1, 2022

    Diabetes Risk Trial in Brussel (evaluation of second line glucose homeostasis)

    Completed
    • Diabetes Mellitus Risk
    • evaluation of second line glucose homeostasis
    • Brussel, Belgium
      Cliniques Universitaires Saint-Luc - UCLouvain
    Aug 8, 2022

    Type 1 Diabetes Trial in Verona (Use of Predictive Alarm for hypoglycaemia or hyperglycaemia, Use of Alarm on Threshold for

    Completed
    • Type 1 Diabetes
    • Use of Predictive Alarm for hypoglycaemia or hyperglycaemia
    • Use of Alarm on Threshold for hypoglycaemia or hyperglycaemia
    • Verona, Italy
      Pediatric Diabetes and Metabolic Disorders Unit, Surgery, Dentis
    Oct 7, 2022

    End Stage Renal Disease, Peritoneal Dialysis Complication Trial in Holbæk (Dapagliflozin 10 MG [Farxiga])

    Enrolling by invitation
    • End Stage Renal Disease
    • Peritoneal Dialysis Complication
    • Dapagliflozin 10 MG [Farxiga]
    • Holbæk, Zealand, Denmark
      University Hospital Copenhagen - Holbaek
    Feb 11, 2022

    End Stage Renal Disease Trial in Düsseldorf, Chieti (XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght,

    Not yet recruiting
    • End Stage Renal Disease
    • XyloCore Low Strenght, XyloCore Medium Strenght, XyloCore High Strenght
    • 1.36%, 1.5%, 2.27%, 2.5%, 3.86%, 2.25% Glucose PD Solution
    • Düsseldorf, Germany
    • +1 more
    Mar 28, 2022

    Type 2 Diabetes, End Stage Renal Disease on Dialysis Trial in Chapel Hill (Semaglutide, Placebo)

    Not yet recruiting
    • Type 2 Diabetes
    • End Stage Renal Disease on Dialysis
    • Chapel Hill, North Carolina
      University of North Carolina
    Sep 11, 2023

    Empagliflozin in Type 2 Diabetes Population With and Without

    Not yet recruiting
    • Diabetes Mellitus, Type 2
    • Durham, North Carolina
      Duke Clinical Research Institute
    Aug 8, 2022

    CHF Trial in Moscow (Standard list of drugs used for acute decompensation of CHF (loop diuretics, vasodilators, digoxin,

    Recruiting
    • Congestive Heart Failure
    • Standard list of drugs used for acute decompensation of CHF (loop diuretics, vasodilators, digoxin, inotropic agents, vasopressors), plus dapagliflozin (Forxiga; MP-002596)
    • Moscow, Russian Federation
    • +1 more
    Mar 15, 2022